About Biocenter Finland
Biocenter Finland (BF) is a distributed national research infrastructure of five biocenters in six Finnish universities:
Biocenter Kuopio, University of Eastern Finland
Helsinki Institute of Life Science HiLIFE, University of Helsinki
Biocenter Oulu, University of Oulu
Faculty of Medicine and Life Sciences, University of Tampere
BioCity Turku, University of Turku and Åbo Akademi University
All universities participating in BF have prioritized life sciences in their current strategies and have endorsed their support to BF for 2017-2020 based on an action plan presented by BF Board.
BF provides research services to the entire Finnish research community, in academia and industry, and to a limited extent also to users abroad. All services are based on the concept of open access. Technology services are provided by BF infrastructure networks in bioinformatics; biological imaging; genome-wide methods; model organisms; proteomics and metabolomics; stem cells and biomaterials; structural biology and biophysics; translational research technologies; and viral gene transfer and cell therapy. Through its infrastructure networks Biocenter Finland is also actively involved in the development pan-European infrastructures on the ESFRI Roadmap.
In 2013, Biocenter Finland was selected for the national roadmap for research infrastructures with excellent reviews. Finland’s strategy and roadmap for research infrastructures 2014–2020.
Scientific Advisory Board
The technology development in all areas of life sciences represented in BF proceeds very fast. To stay at the cutting edge, BF closely follows international developments in instrumentation and technologies. All its activities are regularly evaluated by an international Scientific Advisory Board (SAB) allowing for dynamic changes in this rapidly moving area. Current compostion (-2016) of BF SAB is Carl-Henrik Heldin, Ole-Petter Ottersen, Marja Jäättelä, Matthias Wilmanns and Gunnar von Heijne.